Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension

Details for Australian Patent Application No. 2004312095 (hide)

Owner CyDex, Inc.

Inventors Thompson, Diane O.; Zimmerer, Rupert O.; Pipkin, James D.; Mosher, Gerold L.

Agent Mills Oakley Patent Attorneys

Pub. Number AU-A-2004312095

PCT Pub. Number WO2005/065651

Priority 60/533,628 31.12.03 US

Filing date 31 December 2004

Wipo publication date 21 July 2005

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

C08B 37/16 (2006.01) Preparation of polysaccharides not provided for in

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/065651 Priority application(s): WO2005/065651

14 August 2008 Alteration of Name

  The name of the applicant has been altered to Cydex Pharmaceuticals, Inc.

16 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004312096-Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid

2004312090-Pharmaceutical composition for thrombin peptide derivatives